Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration

Nature Medicine

Volumn 5, Issue 7, 1999, Pages 753-759

  Bonadio, Jeffrey ^a,b   Smiley, Elizabeth ^a   Patil, Pravin ^a   Goldstein, Steven ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Selective Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

ARTICLE; BONE GROWTH; GENE ACTIVATION; GENE EXPRESSION; GENE THERAPY; HUMAN; OSSIFICATION; PRIORITY JOURNAL; REPRODUCIBILITY; TISSUE REGENERATION;

ANIMALS; BONE REGENERATION; DOGS; FEMUR; GENE THERAPY; HUMANS; OSTEOTOMY; PARATHYROID HORMONE; PLASMIDS; RECOMBINANT PROTEINS; TERIPARATIDE; TIBIA;

EID: 0033021062     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/10473     Document Type: Article

References (36)

1. Abraham, J.A. & Klagsbrun, M. in The Molecular and Cellular Biology of Wound Repair (ed. Clark, R.A.F.) 195-248 (Plenum, New York, 1996).
2. Langer, R. Drug delivery and targeting. Nature 392 (suppl.), 5-10 (1998).
3. Bartus, R.T., Tracy, M.A., Emerich, D.F. & Zale, S.E. Sustained delivery of proteins for novel therapeutic products. Science 281, 1161-1162 (1998).
4. Terrell, T.G., Working, P.K., Chow, C.P. & Green, J.D. Pathology of recombinant human transforming growth factor-β1 in rats and rabbits. Int Rev. Exp. Pathol. 34B, 43-67 (1993).
5. Shea, L.D., Smiley, E., Bonadio, J. & Mooney, D.J. Controllable DNA delivery from three-dimensional polymer matrices. Nature Biotechnol. 17, 551-554 (1999).
6. Lew, D. et al. Cancer gene therapy using plasmid DNA: Pharmacokinetic study of DNA following injection in mice. Hum. Gene Therapy 6, 553-564 (1995).
7. Schleef, M. in Biotechnology (eds. Rehm, H-J., and Reed, G.) 443-469 (Wiley-VCH, Weinheim, FRG, 1999).
8. Parker, S.E. et al. Cancer gene therapy using plasmid DNA: Safety evaluation in rodents and non-human primates. Hum. Gene Therapy 6, 575-590 (1995).
9. Urist, M. Bone: Formation by autoinduction. Science 150, 893-899 (1965).
10. Fang, J. et al. Stimulation of new bone formation by direct transfer of osteoinductive plasmid genes. Proc. Natl. Acad. Sci. USA 93, 5753-5758 (1996).
11. Langer, R. & Vacanti, J.P. Tissue engineering. Science 260, 920-925 (1993).
12. Verma, I.M. & Somia, N. Gene therapy - promises, problems and prospects. Nature 389, 239-242 (1997).
13. Kay, M.A., Liu, D. & Hoogerbrugge, P.M. Gene therapy. Proc. Natl. Acad. Sci. USA 94, 12744-12746 (1997).
14. Feldman, A.M. & Lee, J.S. Gene therapy for therapeutic myocardial angiogenesis: A promising synthesis of two emerging technologies. Nature Med. 4, 739-742 (1998).
15. Martin, P. Wound healing - aiming for perfect skin. Science 276, 75-81 (1997).
16. Bonadio, J., Goldstein, S.A., and Levy, R.J. (1998) Gene therapy for tissue repair and regeneration. Adv. Drug Delivery Rev. 33, 53-69.
17. Giannobile, W.V. Periodontal tissue engineering by growth factors. Bone 19 (1 Suppl), 23S-37S (1996).
18. Singh, R.H. & Udupa, K.N. Studies on the effect of parathormone and vitamin D in healing of fractures. Indian J. Med. Res. 54, 872-880 (1966).
19. Parsons, J.A. & Reit, B. Chronic response of dogs to parathyroid hormone infusion. Nature 250, 254-257 (1974).
20. Gunness-Hey, M. & Hock, J.M. Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats. Bone 10, 447-452 (1989).
21. Lindsay, R. et al. Randomized controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350, 550-555 (1997).
22. Podbesek, R. et al. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 112, 1000-1016 (1983).
23. Podbesek, R. et al. in Hormonal Control of Calcium Metabolism 118-123 (ed., Potts, J.J.)(Exerpta Medica, Amsterdam, 1980).
24. Parsons, J.A., Meunier, P.J., Neer, R.M., Podbesek, R. & Reeve, J. in Osteoporosis (eds. DeLuca, H.F., Frost, H.M., Lee, J.S.S., Johnston Jr., C.C. & Parfitt, A.M.) 457-465 (University Park, Baltimore, 1981).
25. Segre, G.V. Principles of Bone Biology (eds. Bilezikian, J.P., Raicz, L.G. & Rodan, G.A.) 377-403 (Academic, San Diego, 1996).
26. Vortkamp, A., Pathi, S., Peretti, G.M., Caruso, E.M., Zaleske, D.J. & Tabin, C.J. Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair. Mech. Dev. 7, 65-76 (1998).
27. Dempster, D.W., Cosman, F., Parisien, M., Shen, V. & Lindsay, R. Anabolic actions of parathyroid hormone on bone. Endocr. Rev. 14, 690-709 (1993).
28. Cosman, F. & Lindsay, R. Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence. Calcif. Tissue Int. 62, 475-480 (1998).
29. Schipani, E., Kruse, K. & Juppner, H. A constituitively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268, 98-100 (1995).
30. Lanske, B. et al. PTH/PTHrP receptor in early development and indian hedgehog-regulated bone growth. Science 273, 663-666 (1996).
31. Canalis, E., Centrella, M., Burch, W. & McCarthy, T.L. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J. Clin. Invest. 83, 60-65 (1989).
32. Jette AM. Harris BA. Cleary PD. Campion EW. (1987) Functional recovery after hip fracture. Arch. Phys. Med. Rehabil. 68, 735-740.
33. Melton, L.J. 3rd. et al. Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J. Bone Miner. Res. 12, 16-23 (1997).
34. Ray, N.F., Chan, J.K., Thamer, M. & Melton, L.J. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J. Bone Miner. Res. 12, 24-35 (1997).
35. Volpon, J.B. Nonunion using a canine model. Arch. Orthop. Trauma Surg. 113, 312-317 (1994).
36. Iotsova, V. et al. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nature Med. 3, 1285-1289 (1997).